Serotonin and Norepinephrine Activity in Anorexia and Bulimia Nervosa: Relationship to Nutrition, Feeding, and Mood

  • Walter H. Kaye
  • Theodore E. Weltzin
  • L. K. G. Hsu
Part of the The Depressive Illness Series book series (DISS, volume 4)


Anorexia and bulimia nervosa (DSM-III-R, 1987) are disorders of unknown etiology which are characterized by alterations of appetitive behavior and distortions of body image. Eating disorder patients have dysphoric mood (Hudson et al., 1983a) and various forms of hypothalamic-pituitary dysfunction.


Anorexia Nervosa Eating Disorder Bulimia Nervosa Eating Disorder Patient Weight Restoration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Abraham SF, Beumont PJV, Cobbin DM: Catecholamine metabolism and body weight in anorexia nervosa. Brit J Psychiatry 1981; 138: 244–247.CrossRefGoogle Scholar
  2. Ananth J, Pecknold JC, Van der Steen N, Engelsmann F: Double-blind compara-tive study of climopramine and amitriptyline in obsessive neurosis. Prog Neuropsychopharmacol Biol Psychiatry 1981; 5: 257–262.Google Scholar
  3. Asbert M, Traskman L, Thoren P: 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193–1197.CrossRefGoogle Scholar
  4. Beary MD, Lacey JH, Merry J: Alcoholism and eating disorders in women of fertile age. Brit J Addiction 1986; 81: 685–689.CrossRefGoogle Scholar
  5. Beaumont PJV, George GCW, Smart DE: “Dieters” and “vomiters” in anorexia nervosa. Psychol Med 1976; 6: 617–622.CrossRefGoogle Scholar
  6. Biederman J, Herzog DB, Rivinus TM, Ferber RA, Harper GP, Orsulak PJ, Harmatz JS, Schildkraut JJ: Urinary MHPG in anorexia nervosa patients with and without a concomitant major depressive disorder. J Psych Res 1984; 18: 149–160.CrossRefGoogle Scholar
  7. Biederman J, Herzog DB, Rivinus TM, et al: Amitryptyline in the treatment of anorexia nervosa: a double-blind study, placebo-controlled study. J Clin Psychopharmacol 1985a; 5: 10–16.PubMedCrossRefGoogle Scholar
  8. Biederman J, Rivinus T, Kemper K, Hamilton D, MacFadyen J, Harmatz, J: Depressive disorders in relatives of anorexia nervosa patients with and without a current episode of nonbipolar major depression. Am J Psychiatry 1985b; 142: 1495–1496.PubMedGoogle Scholar
  9. Blouin AG, Glouin JF, Perez EL, Bushnik T, Zuro C, Mulder E: Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol 1988; 8: 261–269.PubMedCrossRefGoogle Scholar
  10. Blundell JE: Serotonin and appetite. Neuropharmacology 1984; 23: 1537–1551.PubMedCrossRefGoogle Scholar
  11. Brewerton TD, Brandt HA, Lesern MD, Murphy DL, Jimerson DC: Serotonin in eating disorders. In: Coccaro EF, Murphy DL (Eds.), Serotonin in Major Psychiatric Disorders. Washington DC: American Psychiatric Press, 1990.Google Scholar
  12. Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF: Aggression in human correlates with cerebrospinal fluid amine metabolites. Psych Res 1979; 1: 131–139.CrossRefGoogle Scholar
  13. Buckholtz N, George DT, Davies AO, Jimerson DC, Potter WZ: Lymphocyte beta-adrenergic receptor modification in bulimia. Arch Gen Psychiat 1988; 45: 479–482.PubMedCrossRefGoogle Scholar
  14. Bulik CM: Drug and alcohol abuse by bulimic women and their families. Am J Psychiatry 1987; 144: 1604–1606.PubMedGoogle Scholar
  15. Cantwell DP, Sturzenburger S, Burroughs J, Salkin B, Green JK: Anorexia ner-vosa. An affective disorder? Arch Gen Psychiatry 1977; 3: 1087–1093.CrossRefGoogle Scholar
  16. Casper RC: Personality features of women with good outcome from restricting anorexia nervosa. Psychosomatic Med 1990; 52: 156–170.Google Scholar
  17. Casper RC, Eckert ED, Halmi KA, Goldberg SC, Davis JM: Bulimia: Its incidence and clinical importance in patients with anorexia nervosa. Arch Gen Psychiatry 1980; 37: 1030–1035.PubMedCrossRefGoogle Scholar
  18. Charney DS, Woods SW, Goodman WK, Heninger GR: Serotonin function in anxiety. Psychopharmacology 1987; 92: 14–24.PubMedCrossRefGoogle Scholar
  19. Chiodo J, Latimer PR: Vomiting as a learned weight-control technique in bulimia. J Behav Ther Exp Psychiatry 1983; 14: 131.PubMedCrossRefGoogle Scholar
  20. Cloninger CR: Neurogenic adaptive mechanism in alcoholism. Science 1987; 235: 410–416.CrossRefGoogle Scholar
  21. Crisp AH, Lacey JH, Crutchfield M: Clomipramine and “drive” in people with anorexia nervosa. Brit J Psychiatry 1987; 50: 355–358.CrossRefGoogle Scholar
  22. Diagnostic and Statistical Manual of Mental Disorders,Washington DC: American Psychiatric Association, Third Edition, 1987.Google Scholar
  23. Eckert ED, Goldberg SC, Halmi KA, Cooper RC, Davis JM: Depression in anorexia nervosa. Psychol Med 1982; 12: 115–122.PubMedCrossRefGoogle Scholar
  24. Esler M: Assessment of sympathetic nervous function in humans for noradrenaline plasma kinetics. Clin Sci 1982; 52: 247.Google Scholar
  25. Freeman, CPL, Hampson M: Fluoxetine as a treatment for bulimia nervosa. Int J Obes 1987; 11 (Suppl 3): 171–177.PubMedGoogle Scholar
  26. Freeman CP, Morris JE, Chesire KE et al: A double-blind controlled trial of fluoxetine versus placebo for bulimia nervosa. Third International Conference on Eating Disorders. New York, NY Abstract, 1988.Google Scholar
  27. Garfinkel PE, Moldofsky H, Garner DM: The heterogeneity of anorexia nervosa. Arch Gen Psychiatry 1980; 37: 1036–1040.PubMedCrossRefGoogle Scholar
  28. Garner DM, Garfinkel PE, O’Shaughnessy M: The validity of the distinction between bulimia with and without anorexia nervosa. Am J Psychiatry 1985; 142: 581–587.PubMedGoogle Scholar
  29. Garner DM, Fairburn C, Davis R: Cognitive-behavioral treatment of bulimia nervosa: A critical appraisal. Psychiatry Res 1990; 33: 1–10.CrossRefGoogle Scholar
  30. Gerner RH, Gwirtsman HE: Neurochemical abnormalities in anorexia nervosa: Similarities to affective disorders. Biol Psychiatry 1981; 16: 991–995.PubMedGoogle Scholar
  31. Gerner RH, Cohen DJ, Fairbanks L, Anderson GM, Young JG, Scheinin M, Linnoila M, Shaywitz BA, Hare TA: CSF neurochemistry of women with anorexia nervosa and normal women. Am J Psychiatry 1984; 141: 1441–1444.PubMedGoogle Scholar
  32. Gershon ES, Schreiber JL, Hamovit JR, Dibble ED, Kaye WH, Nurnberger J, Anderson A, Ebert MH: Clinical findings in patients with anorexia nervosa and affective illness in their relatives. Am J Psychiatry 1984; 141: 1419–1422.PubMedGoogle Scholar
  33. Goldbloom DS, Hicks L, Garfinkel PE: Platelet serotonin uptake in bulimia nervosa. Biol Psychiatry 1990; 28: 644–647.PubMedCrossRefGoogle Scholar
  34. Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS: Efficacy of fluvoxamine in obsessive compulsive disorders. Arch Gen Psychiatry 1989; 20: 1174–1188.Google Scholar
  35. Goodwin GM, Fairburn CG, Cowen PJ: The effects of dieting and weight loss on neuroendocrine responses to tryptophan, clonidine, and apomorphine in volunteers: Important implications for neuroendocrine investigations in depression. Arch Gen Psychiatry 1988; 44: 952–957.CrossRefGoogle Scholar
  36. Gross HA, Lake CR, Ebert MH, Ziegler MG, Kopin IJ: Catecholamine metabo-lism in primary anorexia nervosa. J Clin Endocrin Metab 1979; 49: 805–809.CrossRefGoogle Scholar
  37. Gross AH, Ebert MH, Faden VB: A double-blind controlled trial of lithium car-bonate in primary anorexia nervosa. J Clin Psychopharmacol 1981; 1: 376–381. Gwirtsman HE, Roy-Byrne P, Yager J, Gerner RH: Neuroendocrine abnormalities in bulimia. Am J Psychiatry 1983; 140: 559–563.Google Scholar
  38. Gwirtsman HE, Kaye WH, Obarzanek E, George DT, Jimerson DT, Ebert MH: Decreased caloric intake in normal-weight patients with bulimia: Comparison with female volunteers. Am J Clin Nutr 1989; 48: 86–92.Google Scholar
  39. Gwirtsman HE, Guze BH, Jager J, Gainsley B: Fluoxetine treatment of anorexia. An open trial. J Clin Psych 1990; 51: 378–382.Google Scholar
  40. Halmi KA, Falk JR, Schwartz E: Binge-eating and vomiting: A survey of a college population. Psychol Med 1981; 11: 697–706.PubMedCrossRefGoogle Scholar
  41. Halmi KA, Eckert ED, LaDu TJ et al: Anorexia nervosa: Treatment efficacy of cyproheptadine and amitriptyline. Arch Gen Psychiatry 1986; 43: 177–181.PubMedCrossRefGoogle Scholar
  42. Hatsukami DK, Eckert ED, Mitchell JE, Pyle RL: Affective disorder and sub- stance abuse among women with bulimia. Psychol Med 1984; 14: 701–704.PubMedCrossRefGoogle Scholar
  43. Hendren RL: Depression in anorexia nervosa. J Am Acad Chld Psychiatry 1983; 22: 59–62.CrossRefGoogle Scholar
  44. Herzog DB: Bulimia in the adolescent. Am J Disord Children 1982; 136: 985–989. Herzog DB, Copeland PM: Eating disorders. N Eng J Med 1985; 313: 295–303.CrossRefGoogle Scholar
  45. Heufelder A, Warnhoff M, Pirke KM: Platelet alpha-2 andrenoceptor and adenyl-ate cyclase in patients with anorexia nervosa and bulimia. J Clin Endocrin Metab 1985; 61: 1053–1060.CrossRefGoogle Scholar
  46. Hsu LKG, Crisp AH, Harding B: Outcome of anorexia nervosa. Lancet 1970; is 61–65.Google Scholar
  47. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D: Phenomenologic relationship of eating disorders to major affective disorders. Psychiatry Res 1983a; 9: 345–354.PubMedCrossRefGoogle Scholar
  48. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D: Family history study of anorexia nervosa and bulimia. Brit J Psychiatry 1983b; 142: 133–138.CrossRefGoogle Scholar
  49. Hudson JI, Pope HG, Jonas JM, Yurgelun-Todd D, Frankenburg FR: A controlled family history study of bulimia. Psychol Med 1987; 17: 883–890.PubMedCrossRefGoogle Scholar
  50. Hughes PL, Wells LA, Cunningham CJ, Ilstrup DM: Treating bulimia with desipramine. Arch Gen Psychiatry 1986; 43: 182–186.PubMedCrossRefGoogle Scholar
  51. Insel TR, Mueller EA, Alterman I, Linnoila M, Murphy DL: Obsessive-compulsive disorder and serotonin: Is there a connection? Biol Psychiatry 1985; 20: 1174–1188.PubMedCrossRefGoogle Scholar
  52. Jimerson DC, Lesern MD, Kaye WH, Brewerton TD: Symptom severity and neurotransmitter studies in bulimia. Psychopharmacology 1988; 96: S124.Google Scholar
  53. Jimerson DC, Lesem MD, Hegg AP, Brewerton TD: Serotonin in human eating disorders, In: The Neuropharmacology of Serotonin, edited by PM WhitakerAzmitia and SJ Peroutka, Ann NY Acad Sci, 1990a; 600: 532–544.Google Scholar
  54. Jimerson DC, Lesern MD, Kaye WH, Hegg AP, Brewerton TD: Eating disorders and depression: Is there a serotonin connection? Biol Psychiatry 1990b; 28: 443–454.PubMedCrossRefGoogle Scholar
  55. Johnson JL, Leiter LA, Burrow GN, Garfinkel PE, Anderson GH: Excretion of urinary catecholamine metabolites in anorexia nervosa: Effect of body composition and energy intake. Am J Clin Nutri 1984; 40: 1001–1006.Google Scholar
  56. Jung RT, Shetty PS, Barrand M, Callingham BA, James WPT: Role of catecholamines in hypotensive response to dieting. Br Med J 1979; 1: 12.PubMedCrossRefGoogle Scholar
  57. Kahn RS, Van Praag MH, Wetzler RS: Serotonin and anxiety revisited. Biol Psychiatry 1988; 23: 189–208.PubMedCrossRefGoogle Scholar
  58. Kassett JA, Gerson ES, Maxwell ME, Guroff JJ, Kazuba DM, Smith AL, Brandt HA, Jimerson DC: Psychiatric disorders in the first-degree relatives of pro-bands with bulimia nervosa. Am J Psychiatry 1986; 11: 1468–1471.Google Scholar
  59. Kasvikis YG, Tsakiris F, Marks IM, Basoglu M, Noshirvani HF: Past history of anorexia nervosa in women with obsessive compulsive disorder. Int J Eating Disorders 1986; 5: 1069–1075.CrossRefGoogle Scholar
  60. Kaye WH, Ebert MHY, Raleigh M, Lake CR: Abormalities in central nervous system monamine metabolism in anorexia nervosa. Arch Gen Psychiatry 1984a; 41: 350–355.PubMedCrossRefGoogle Scholar
  61. Kaye WH, Ebert MH, Gwirtsman HE, Weiss SR: Differences in brain serotonin metabolism between nonbulimic and bulimic patients with anorexia nervosa. Am J Psychiatry 1984b; 141: 1598–1601.PubMedGoogle Scholar
  62. Kaye WH, Gwirtsman HE, Lake CR, Siever LJ, Jimerson DC, Ebert MH, Murphy DL: Disturbances of norepinephrine metabolism and alpha2 adrenergic receptor activity in anorexia nervosa: Relationship to nutritional state. Psychopharm Bull 1985a; 21: 419–423.Google Scholar
  63. Kaye WH, Jimerson DC, Lake CR, Ebert MH: Altered norepinephrine metabolism following long-term weight recovery in patients with anorexia nervosa. Psych Res 1985b; 14: 333–342.CrossRefGoogle Scholar
  64. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH: CSF 5-HIAA concentrations in anorexia nervosa: Reduced values in underweight subjects normalize after weight gain. Biol Psychiatry 1988a; 23: 102–105.PubMedCrossRefGoogle Scholar
  65. Kaye WH, Gwirtsman H, Jimerson DC, George DT, Karoum F, Ebert MH, Lake CR: Catecholamine function in anorexia nervosa at low weight and after weight restoration. Prog Catecholamine Res, Part C: Clin Aspects 1988b; 355–361.Google Scholar
  66. Kaye WH, Gwirtsman HE, Brewerton TD, George DT, Wurtman RJ: Bingeing behavior and plasma amino acids: A possible involvement of brain serotonin in bulimia nervosa. Psychiatry Research, 1988c; 23: 31–43.PubMedCrossRefGoogle Scholar
  67. Kaye WH, Gwirtsman HE, George DT, Jimerson DC, Ebert MH, Lake CR: Disturbances of noradrenergic systems in normal-weight bulimia:Relationship to diet and menses. Biol Psychiatry 1990a; 27: 4–21.PubMedCrossRefGoogle Scholar
  68. Kaye WH, Ballenger JC, Lydiard B, Stuart GW, Laraia MT, O’Neil P, Fossey M, Stevens V, Lesser S, Hsu LKG: CSF Monoamine levels in normal-weight bulimia: Evidence for abnormal noradrenergic activity. Am J Psychiatry 1990b; 147: 225–229.PubMedGoogle Scholar
  69. Kaye WH, Gwirtsman HE, George DT, Ebert MH: Altered serotonin activity in anorexia nervosa after long-term weight restoration: Does elevated CSF 5-HIAA correlate with rigid and obsessive behavior? Arch Gen Psychiatry, 1991a; 48: 556–562.PubMedCrossRefGoogle Scholar
  70. Kaye WH, Weltzin TE, Hsu LKG, Bulik C: An open trial of fluoxetine in patients with anorexia nervosa. Journal of Clinical Psychiatry, 1991b; 52: 464–471.PubMedGoogle Scholar
  71. Kennedy SH, Piran N, Garfinkel OE: Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid. J Clin Psychopharmacol 1985; 5: 279–285.PubMedCrossRefGoogle Scholar
  72. Kennedy S, Piran N, Garfinkel PE: Isocarboxazede in the treatment of bulimia. Am J Psychiatry 1986; 143: 1495–1496.PubMedGoogle Scholar
  73. Keys A: The Biology of Human Starvation, Minneapolis: University of Minnesota Press, 1950.Google Scholar
  74. King A: Primary and secondary anorexia nervosa syndromes. Br J Psychiatry 1963; 109: 470–479.PubMedCrossRefGoogle Scholar
  75. Krahn D, Mitchell J: Use of L-tryptophan in treating bulimia (letter). Am J Psychiatry 1985; 142: 1130.PubMedGoogle Scholar
  76. Lacey JH, Crisp AH: Hunger, food intake and weight: the impact of clomipram-ine on a refeeding anorexia nervosa population. Postgrad Med J 1980; 56: 79–85.PubMedGoogle Scholar
  77. Laessle RG, Wittchen HU, Fichter MM, Pirke KM: The significance of subgroups of bulimia and anorexia nervosa: lifetime frequency of psychiatric disorders. Int J Eat Disord 1989; 8: 569–574.CrossRefGoogle Scholar
  78. Landsberg L, Young JB: Fasting, feeding and the regulation of sympathetic activity. N Engl J Med 1978; 298: 1295–1301.PubMedCrossRefGoogle Scholar
  79. Leibowitz SF: Noradrenergic function in the medial hypothalamus: Potential relation to anorexia nervosa and bulimia. In Pirke KM, Ploog D (Eds.), The Psychbiology of Anorexia Nervosa. Berlin: Springer-Verlag, 1984, p. 35.CrossRefGoogle Scholar
  80. Leibowitz SF, Shor-Posner G: Brain serotonin and eating behavior. Appetite 1986; 7: 1–14.PubMedCrossRefGoogle Scholar
  81. Leibowitz SF, Weiss GF, Yee F, Tretter JB: Noradrenergic innervation of the paraventricular nucleus: Specific role in control of carbohydrate ingestion. Brain Res Bull 1985; 14: 561–567.PubMedCrossRefGoogle Scholar
  82. Leon GR, Carroll K, Chernyk B, Finn S: Binge eating and associated habit patterns within college student and identified bulimic populations. In J Eating Disord 1985; 4: 43–57.CrossRefGoogle Scholar
  83. Lesom M, George DT, Kaye WH, Goldstein DS, Jimerson DC: State-related changes in norepinephrine regulation in anorexia nervosa. Biol Psychiatry 1989; 25: 509–512.CrossRefGoogle Scholar
  84. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-HIAA concentration differentiates impulsive from non-impulsive violent behavior. Life Sci 1983; 33: 2609–2614.PubMedCrossRefGoogle Scholar
  85. Lonati-Galligani M, Pirke KM: Beta2-adrenergic receptor regulation in circulating mononuclear leukocytes in anorexia nervosa and bulimia. Psych Res 1986; 19: 189–198.CrossRefGoogle Scholar
  86. Luck P, Mikhailidis DP, Dashwood MR, Barradas MA, Sever PS, Dandona P, Wakeling A: Platelet hyperaggregability and increased alpha-adrenoceptor density in anorexia nervosa. J Clin Endocrin Metab 1983; 57: 911–914.CrossRefGoogle Scholar
  87. Mira M, Abraham S: L-tryptophan as an adjunct to treatment of bulimia nervosa (letter). Lanet 1989; ii: 1162–1163.Google Scholar
  88. Mitchell JE, Groat R: A placebo-controlled double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol 1984; 4: 186–193.PubMedCrossRefGoogle Scholar
  89. Mitchell JE, Hatsukami D, Eckert ED, Pyle RL: Characteristics of 275 patients with bulimia. Am J Psychiatry 1985; 142: 482–485.PubMedGoogle Scholar
  90. Mitchell JE, Hatsukami D, Pyle R, Eckert E: Bulimia with and without a family history of drug abuse. Addictive Behav 1988; 13: 245–251.CrossRefGoogle Scholar
  91. Morgan H, Russell GFM: Value of family background and clinical features as predictors of long-term outcome in anorexia nervosa: Four-year follow-up study of 41 patients. Psychol Med 1975; 5: 355–371.PubMedCrossRefGoogle Scholar
  92. Myers RD, McCaleb ML: Feeding, satiety signal from intestine triggers brain’s noradrenergic mechanism. Science 1980; 209: 1035–1037.PubMedCrossRefGoogle Scholar
  93. Newman MM, Halmi KA, Marchi P: Relationship for clinical factors to calo-ric requirements in subtypes of eating disorders. Biol Psychiatry 1987; 22: 1253–1263.PubMedCrossRefGoogle Scholar
  94. Obarzanek E, Lesern M, Jimerson DC: Resting metabolic rate in bulimic patients (NR 204). Presented at the 140th Annual Meeting of the American Psychiatric Association, Chicago, 1990.Google Scholar
  95. Pahl J, Pirke KM, Schweiger U, Warnhoff M, Gerlinghoff M, Brinkmann W, Berger M, Krieg C: Anorectic behavior, mood, and metabolic and endocrine adaptation to starvation in anorexia nervosa during inpatient treatment. Biol Psychiatry 1985; 20: 874–887.PubMedCrossRefGoogle Scholar
  96. Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R: Fluvoxamine treatment of obsessive compulsive disorder. Am J Psychiatry 1987; 144: 1543–1548.PubMedGoogle Scholar
  97. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA:Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077–1083.PubMedCrossRefGoogle Scholar
  98. Pfeiffer A, Herz A: Endocrine actions of opioids. Horm Metabol Res 1984; 16: 386–397.CrossRefGoogle Scholar
  99. Pirke KM, Spyra B: Catecholamine turnover in the brain and the regulation of luteinizing hormone and corticosterone in starved male rats. Acat Endocrinol 1982; 100: 168–176.Google Scholar
  100. Pirke KM, Fichter MM, Pahl J: Noradrenaline, trijodthyronine, growth hormone and prolactin during weight gain in anorexia nervosa. Int J Eat Dis 1985a; 4: 499–509.CrossRefGoogle Scholar
  101. Pirke KM, Pahl J, Schweiger U, Warnhoff M: Metabolic and endocrine indices of starvation in bulimia: A comparison with anorexia nervosa. Psych Res 1985b; 15: 33–39.CrossRefGoogle Scholar
  102. Pirke KM, Ploog D: Psychobiology of anorexia nervosa. In: Wurtman RJ, Wurt-man JJ (Eds.), Nutrition and the Brain, New York: Raven Press, 1986, Vol. 7. Pirke KM, Eckert M, Ofers B, et al: Plasma norepinephrine response to exercise in bulimia, anorexia nervosa and controls. Biol Psychiat 1989; 25: 799–802.Google Scholar
  103. Ploog D, Pirke KM: The Psychobiology of Anorexia Nervosa. Berlin: Springer-Verlag, 1984, 35–45.Google Scholar
  104. Pope HG, Hudson JI: Antidepressant drug therapy for bulimia: Current status. J Clin Psychiatry 1986; 47: 339–345.PubMedGoogle Scholar
  105. Pope HG, Hudson JI, Jonas JM, et al.: Bulimia treated with imipramine: A placebo controlled double-blind study. Am J Psychiatry 1983; 140: 554–558.PubMedGoogle Scholar
  106. Pope HG, Hudson JI, Yurgelun-Todd D: Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry 1984; 141: 292–294.PubMedGoogle Scholar
  107. Potter WZ, Muscettola G, Goodwin FK: Source of variance in clinical studies of MHPG. In: Maas JW (Ed.), MHPG: Base Mechanisms and Psychopathology, New York: Academic Press, 1983.Google Scholar
  108. Pyle RL, Mitchell JE, Eckert ED: Bulimia: A report of 34 cases. J Clin Psychiatry 1981; 42: 60–64.PubMedGoogle Scholar
  109. Riederer P, Toifl K, Kruzik P: Excretion of biogenic amine metabolites in anorexia nervosa. Clin Chem Acta 1982; 123: 27–32.CrossRefGoogle Scholar
  110. Rothenberg A: Differential diagnosis of anorexia nervosa and depressive illness: A review of 11 studies. Comp Psychiatry 1988; 29: 427–432.CrossRefGoogle Scholar
  111. Rowland C Jr: Anorexia nervosa. A survey of the literature and review of 30 cases. Int J Psych Clin 1970; 7: 37–137.Google Scholar
  112. Russell GFM, Checkley SA, Feldman J, Eisler I: A controlled trial of d-fenfluram-ine in bulimia nervosa. Clin Neuropharmacol 1988; 11 (Supple 1): S146 - S159.PubMedGoogle Scholar
  113. Silver JA: Anorexia nervosa: Clinical observations in a successful treatment plan. J Pediatr 1974; 84: 68.CrossRefGoogle Scholar
  114. Soubrie P: Reconciling the role of central serotonin neurosis in human and animal behavior. Behav Brain Sci 1986; 9: 319–363.CrossRefGoogle Scholar
  115. Stangler RS, Printz AM: DSB-III psychiatric diagnosis in a university population. Am J Psychiatr 1980; 137: 937–940.PubMedGoogle Scholar
  116. Stonehill E, Crisp AH: Psychoneurotic characteristics of patients with anorexia nervosa before and after treatment and at follow-up 4–7 years later. J Psychosom Res 1977; 21: 187–193.CrossRefGoogle Scholar
  117. Strober M: Personality and symptomatological features in young, nonchronic anorexia nervosa patients. J Psychosom Res 1980; 24: 353–359.PubMedCrossRefGoogle Scholar
  118. Strober M, Katz JL: Depression in the eating disorders: A review and analysis of descriptive, family, and biological findings. In: Garner DM, Garfinkel PE (Eds.), Diagnostic Issues in Anorexia Nervosa and Bulimia Nervosa: New York: Brunner/Mazel, 1988, 80–111.Google Scholar
  119. Strober M, Lampert C, Morrell W, Burroughs J, Jacobs C: A controlled family study of anorexia nervosa: Evidence of familial aggregation and lack of shared transmission with affective disorders, Int J Eating Dis 1990; 9: 239–253.CrossRefGoogle Scholar
  120. Strober M, Salkin B, Burroughs J, Morrell W: Validity of the bulimia-restricter criteria in anorexia nervosa. J Nervous Mental Dis 1982; 170: 345–351.CrossRefGoogle Scholar
  121. Swift WJ, Andrews D, Barklage NE: The relationship between affective disorder and eating disorders: A review of the literature. Am J Psychiatry 1986; 143: 290–299.PubMedGoogle Scholar
  122. Theander S: Anorexia nervosa: A psychiatric investigation of 94 female patients. Acta Psychiat Scand 1970; Suppl 214.Google Scholar
  123. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L: Clomipramine treatment of obsessive-compulsive disorder in a controlled clinical trial. Arch Gen Psychiatry 1985; 37: 1281–1285.CrossRefGoogle Scholar
  124. Van Loon GR: Abnormal catecholamine mechanisms in hypothalamic-pituitary disorders. Metabolism 1980; (Suppl. 1) 29: 1198–1202.Google Scholar
  125. Van Praag HM: CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet 1983; ii: 977–978.Google Scholar
  126. Volavka J, Neziroglu F, Yaryura-Tobias JA: Clomipramine and imipramine in obsessive compulsive disorder. Psych Res 1985; 14: 85–93.CrossRefGoogle Scholar
  127. Walsh BT, Stewart JW, Roose SP, et al.: Treatment of bulimia with phenelzine: A double-blind, placebo controlled study. Arch Gen Psychiatry 1984; 41: 1105–1109.PubMedCrossRefGoogle Scholar
  128. Warren MP, Vandewiele RL: Clinical and metabolic features of anorexia nervosa. Am J Obstet Gynecol 1973; 117: 435.PubMedGoogle Scholar
  129. Weisman R, Carmi M, Tyano S, Apter A, Rehavi M: High affinity [3H-imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa. Life Sci 1986; 38: 1235–1242.CrossRefGoogle Scholar
  130. Welle S, Lilavivathana U, Campbell RG: Increased plasma norepinephrine concentrations and metabolic rates following glucose ingestion in man. Metabolism 1980; 29: 806–809.PubMedCrossRefGoogle Scholar
  131. Welle S, Lilavivathana U, Campbell RG: Thermic effects of feeding in man: Increased plasma norepinephrine levels following glucose, but not protein or fat consumption. Metab Exp 1981; 30: 953–958.CrossRefGoogle Scholar
  132. Wurtman JJ, Wurtman RJ: Drugs that enhance central serotoninergic transmission diminish elective carbohydrate consumption by rats. Life Science 1979; 24: 895–903.CrossRefGoogle Scholar
  133. Young JB, Rowe JW, Pallotta JA, Sparrow D, Landsbert L: Enhanced plasma norepinephrine response to uptight posture and oral glucose administration in elderly human subjects. Metab Clin Exp 1980; 29: 532–539.PubMedCrossRefGoogle Scholar
  134. Zemishlany Z, Modai A, Apter A, Jerushalmy Z, Samuel E, Tyano S: Serotonin (5-HT) uptake by blood platelets in anorexia nervosa. Acta Psychiatr Scand 1987; 75: 127–130.PubMedCrossRefGoogle Scholar
  135. Zohar J, Insel RH, Zohar-Kadouch RC, Hill JL, Murphy DL: Serotonergic responsivity in obsessive-compulsive disorder: Effects of chronic clomipramine treatment. Arch Gen Psychiatry 1988; 45: 167–172.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • Walter H. Kaye
    • 1
  • Theodore E. Weltzin
    • 1
  • L. K. G. Hsu
    • 1
  1. 1.Department of PsychiatryUniversity of Pittsburgh, School of MedicinePittsburghUSA

Personalised recommendations